drugset / Trial / NCT01464983

Placebo and Active Controlled, Double Dummy Study to Compare Efficacy of Aspirin and Ibuprofen in Treatment of Episodic Tension-type Headache

NCT01464983 ↗

Phase 4 Completed 1115 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine the efficacy and tolerability of 500 mg and 1000 mg Aspirin® (study medication) by comparing it to placebo (the control group without active substance) or 200 mg or 400 mg Ibuprofen (study medication) in treating the symptoms of episodic tension-type headache. The study is designed to develop a treatment method against episodic tension-type headache which will have more advantages for patients than the methods that are currently available.

Timeline

Start
2004-01
Primary completion
—
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Aspirin Small molecule 500 mg Oral
Subject Aspirin Small molecule 1000 mg Oral
Comparator Ibuprofen Small molecule 200 mg Oral
Comparator Ibuprofen Small molecule 400 mg Oral

Indications